Management of the extrapyramidal manifestations of phenylketonuria with L-dopa-Reference-Cited by-同舟云学术

Management of the extrapyramidal manifestations of phenylketonuria with L-dopa

Published:1983-06-01 Issue:6 Volume:58 Page:457-458
ISSN:0003-9888
Container-title:Archives of Disease in Childhood
language:en
Short-container-title:Archives of Disease in Childhood

Author:

MacLeod M D,Munro J F,Ledingham J G,Farquhar J W

Publisher

BMJ

Subject

Pediatrics, Perinatology and Child Health

Reference3 articles.

1. Phenylketonuria in pediatric practice;Farquhar, J.W.; Richmond, J.; Tait, H.P.;Clin Pediatr (Phila),1963

2. The variability in manifestations of untreated patients with phenylketonuria (phenylpyruvic aciduria). Pediatrics 1957; 20: 290-302. 3Anonymous. The duration of treatment of phenylketonuria;Payne, R.S.;Lancet,1974

3. Pathogenesis of phenylketonuria: inhibition of dopa and catecholamine synthesis in patients with phenylketonuria;H-cH, I.Curtius; K, Baerlocher; JA, Volimin;Clin Chim Acta,1972

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and neuropsychological outcomes for children with phenylketonuria in Upper Egypt; a single-center study over 5 years;Neuropsychiatric Disease and Treatment;2018-10

2. Adult-onset phenylketonuria with rapidly progressive dementia and parkinsonism;Neurocase;2016-03-10

3. Clinicolaboratory profile of phenylketonuria (PKU) in Sohag University Hospital-Upper Egypt;Egyptian Journal of Medical Human Genetics;2013-07

4. L-dopa-responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings;Movement Disorders;2004-10

5. Neuropsychology of Early-treated Phenylketonuria: Specific Executive Function Deficits;Child Development;1990-12